Doug Gessl
Director of Finance/CFO at Ception Therapeutics, Inc.
Profile
Doug Gessl is currently the Chief Financial Officer at Ception Therapeutics, Inc. Prior to this, he held positions as Principal at Tucker Anthony Sutro and Nesbitt Burns, Inc., Principal at JPMorgan Chase & Co., Vice President-Finance & Administration at Fulcrum Pharmaceuticals, Inc., Chief Operating & Financial Officer at Ceptaris Therapeutics, Inc., and Senior Vice President at Einhorn Associates, Inc. Gessl holds an MBA from The University of Chicago and an undergraduate degree from the University of Wisconsin.
Doug Gessl active positions
Companies | Position | Start |
---|---|---|
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Director of Finance/CFO | - |
Former positions of Doug Gessl
Companies | Position | End |
---|---|---|
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Director of Finance/CFO | - |
JPMORGAN CHASE & CO. | Corporate Officer/Principal | - |
Nesbitt Burns, Inc. | Corporate Officer/Principal | - |
Tucker Anthony Sutro | Corporate Officer/Principal | - |
Einhorn Associates, Inc. | Corporate Officer/Principal | - |
Training of Doug Gessl
The University of Chicago | Masters Business Admin |
University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JPMORGAN CHASE & CO. | Finance |
Private companies | 6 |
---|---|
Tucker Anthony Sutro | Finance |
Fulcrum Pharmaceuticals, Inc. | Health Technology |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
Nesbitt Burns, Inc. | Finance |
Einhorn Associates, Inc. | Finance |
- Stock Market
- Insiders
- Doug Gessl